International Immunology, Vol. 5, No. 9, pp. 1023-1033,September 1993
© 1993 Japanese Society for Immunology
The role of macrophages in antigen presentation and T cell tolerance
Institute of Molecular Embryology and Genetics, Kumamoto University Medical School Kuhonji, Kumamoto 862, Japan
1 Division of Radiation Health, National Institute of Radiological Sciences Anagawa, Inage-ku, Chiba 263, Japan
2Present address: Laboratoire de Génétique Moleculaire des Eurkaryotes du CNRS Unité 184 de Biologie Moleculaire et de Génie Génétique de I'INSERM, Institut de Chimie Biologique, Faculté de Médecine rue Humann, 67085 Strasbourg Cedex, France
Correspondence to: Correspondence to: G. Suzuki
Bone marrow derived cells (dendritic cells, macrophages and B cells) are involved in antigen presentation and T cell tolerance. However, the precise functions of each cell type remain unclear. To determine the role of macrophages we produced transgenic mice expressing I-E molecules only on macrophages, by introducing the hybrid gene containing the colony stimulating factor-1 (CSF-1) receptor promoter region and the structural gene encoding E
d into C57BL/6 mice. In these mice I-E restricted antigen presentation and T cell priming were impaired. With respect to T cell tolerance, I-E reactive T cells were energized but not clonally deleted. These results clearly demonstrate that macrophages by themselves are defective in efficient I-E restricted antigen presentation, so that T cells exposed to antigens expressed on macrophages are led to anergy.
Keywords: c-fms, class II MHC, clonal anergy, macrophage, transgenic mouse
Received 5 April 1993, accepted 14 May 1993.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Gereke, S. Jung, J. Buer, and D. Bruder Alveolar Type II Epithelial Cells Present Antigen to CD4+ T Cells and Induce Foxp3+ Regulatory T Cells Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 344 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-Y. Pan, G. X. Wang, B. Yin, J. Ozao, T. Ku, C. M. Divino, and S.-H. Chen Reversion of immune tolerance in advanced malignancy: modulation of myeloid-derived suppressor cell development by blockade of stem-cell factor function Blood, January 1, 2008; 111(1): 219 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T. Hagymasi, A. M. Slaiby, M. A. Mihalyo, H. Z. Qui, D. J. Zammit, L. Lefrancois, and A. J. Adler Steady State Dendritic Cells Present Parenchymal Self-Antigen and Contribute to, but Are Not Essential for, Tolerization of Naive and Th1 Effector CD4 Cells J. Immunol., August 1, 2007; 179(3): 1524 - 1531. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Higgins, M. A. Mihalyo, P. W. McGary, and A. J. Adler CD4 Cell Priming and Tolerization Are Differentially Programmed by APCs upon Initial Engagement J. Immunol., June 1, 2002; 168(11): 5573 - 5581. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sotomayor, I. Borrello, F.-M. Rattis, A. G. Cuenca, J. Abrams, K. Staveley-O'Carroll, and H. I. Levitsky Cross-presentation of tumor antigens by bone marrow-derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression Blood, August 15, 2001; 98(4): 1070 - 1077. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kleindienst, I. Chretien, T. Winkler, and T. Brocker Functional comparison of thymic B cells and dendritic cells in vivo Blood, April 15, 2000; 95(8): 2610 - 2616. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Adler, D. W. Marsh, G. S. Yochum, J. L. Guzzo, A. Nigam, W. G. Nelson, and D. M. Pardoll CD4+ T Cell Tolerance to Parenchymal Self-Antigens Requires Presentation by Bone Marrow-derived Antigen-presenting Cells J. Exp. Med., May 18, 1998; 187(10): 1555 - 1564. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Page, E. M. Roberts, J. J. Peschon, and S. M. Hedrick TNF Receptor-Deficient Mice Reveal Striking Differences Between Several Models of Thymocyte Negative Selection J. Immunol., January 1, 1998; 160(1): 120 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Tenen, R. Hromas, J. D. Licht, and D.-E. Zhang Transcription Factors, Normal Myeloid Development, and Leukemia Blood, July 15, 1997; 90(2): 489 - 519. [Full Text] [PDF] |
||||
![]() |
T. Brocker, M. Riedinger, and K. Karjalainen Targeted Expression of Major Histocompatibility Complex (MHC) Class II Molecules Demonstrates that Dendritic Cells Can Induce Negative but Not Positive Selection of Thymocytes In Vivo J. Exp. Med., February 3, 1997; 185(3): 541 - 550. [Abstract] [Full Text] [PDF] |
||||



